Efficacy and safety of vildagliptin in combination with pioglitazone in drug naive patients with type 2 diabetes.
Phase of Trial: Phase III
Latest Information Update: 24 May 2017
At a glance
- Drugs Vildagliptin (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 04 May 2012 Actual end date Jan 2006 added as reported by ClinicalTrials.gov.
- 01 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History